Press Release

Regenerative Medicine Market Will Reach US$ 151,949.5 Mn By 2026: says Fortune Business Insights

Regenerative Medicine Market Expansion to be Persistent During 2019 – 2026, says Fortune Business Insights

The Global Regenerative Medicine Market is likely to expand considerably in the coming years due to growing applications in the treatment of chronic diseases. According to a report published by Fortune Business Insights, titled “Regenerative Medicine: Global Regenerative Medicine Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 23,841.5 Mn in 2018.

Recent developments in treatment of acute and chronic diseases can be attributed to advances in regenerative medicines. Regenerative medicine mainly focus on identifying the root cause of the disease and aims at locating, repairing, and regenerating the non-functioning body cells. As most of the chronic and acute diseases are inclined towards the elderly and geriatric population, the growing geriatric population serves growth of the global regenerative medicine market in the coming years. The ability of regenerative medicine to reduce the burden for some of the most severe chronic diseases will create a high demand for the products in the coming years. Furthermore, applications of regenerative medicine in treatment of diabetic ulcers and chemotherapy will favor the growth of the market in the forthcoming years.

Get [email protected] https://www.fortunebusinessinsights.com/enquiry/check-discount/regenerative-medicine-market-100970

Fortune Business Insights some of the leading companies that have made significant growth contributions to the global market. Besides this, the report identifies some of the attractive business strategies that have been adopted by renowned companies in the world. Some of the leading companies that are operating in the market are

  • Integra LifeSciences Corporation,
  • CELGENE CORPORATION,
  • Medtronic,
  • American CryoStem Corporation,
  • Tissue Regenix,
  • Avita Medical,
  • Osiris Therapeutics, Inc.,
  • Wright Medical Group N.V.,
  • Smith & Nephew,
  • Integra LifeSciences Corporation.

Secondary Data Sources That We Refer To

  • Annual reports, investor presentation, SEC filings, and press releases of companies operating in the market
  • Studies published by relevant associations MedTech Europe; American College of Radiology; Cancer Council Australia; Japan Hospital Association, etc.), government sources (Centers for Disease Control & Prevention, Ministry of Health, Labour & Welfare, Japan; National Health Service, England, etc.), international organizations (World Health Organization, The Organization for Economic Co-operation and Development, Eurostat, etc.), and articles published by Research Gate, NCBI, etc.
  • Website, reports, and press releases of end user facilities – Hospitals, Ambulatory Surgery Centres, Clinics

Segmentation

By Product

  • Cell Therapy
  • Gene Therapy
  • Tissue Engineering
  • Platelet Rich Plasma

By Application

  • Orthopedics
  • Wound Care
  • Oncology
  • Others

By Distribution Channel

  • Hospitals
  • Clinics
Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close